4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000132
EVP Commercial sold 1,000 shares at $844.61 ($844,610)
- EVP Commercial acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McCourt Marion · EVP Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,000 | $381.40 | $381,400 | 13,931 | D |
| 2024-11-01 | Sale : show line 2 in the form 10b5-1 | −1,000 | $844.61 | $844,610 | 12,931 | D |
| Open-market sales · 1,000 sh · avg $844.61 · $844,610 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-01 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,000 | 6,000 | D |
Loading xslF345X05/edgardoc.xml…